Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) shares dropped 8.1% on Wednesday. The company traded as low as $85.68 and last traded at $89.6050. 243,529 shares changed hands during trading, a decline of 56% from the average daily volume of 559,001 shares. The stock had previously closed at $97.50.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on BLLN shares. Weiss Ratings raised Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research note on Monday, November 9th. BTIG Research restated a "buy" rating and set a $130.00 target price on shares of Billiontoone in a report on Thursday, November 5th. Canaccord Genuity Group began coverage on shares of Billiontoone in a research report on Wednesday, September 2nd. They issued a "buy" rating and a $120.00 target price on the stock. Wall Street Zen cut shares of Billiontoone from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Finally, Piper Sandler reduced their price objective on Billiontoone from $140.00 to $130.00 and set an "overweight" rating for the company in a research report on Tuesday, November 10th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $124.38.
View Our Latest Analysis on Billiontoone
Billiontoone Price Performance
The firm has a fifty day moving average of $106.90 and a 200 day moving average of $97.87. The company has a market capitalization of $4.45 billion and a P/E ratio of 101.58. The company has a current ratio of 11.25, a quick ratio of 10.89 and a debt-to-equity ratio of 0.16.
Insider Transactions at Billiontoone
In other news, CTO David Tsao sold 20,000 shares of the business's stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total transaction of $2,184,800.00. Following the completion of the transaction, the chief technology officer directly owned 1,000 shares of the company's stock, valued at $109,240. The trade was a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Bosch John Roderick Ten sold 2,834 shares of the stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $113.17, for a total transaction of $320,723.78. Following the transaction, the senior vice president owned 16,551 shares in the company, valued at approximately $1,873,076.67. This trade represents a 14.62% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 252,777 shares of company stock worth $26,737,151 over the last three months. 50.22% of the stock is currently owned by company insiders.
Institutional Trading of Billiontoone
Hedge funds have recently bought and sold shares of the company. Sei Investments Co. bought a new position in Billiontoone in the 1st quarter worth $1,058,000. The Manufacturers Life Insurance Company lifted its holdings in Billiontoone by 151.8% during the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company's stock valued at $2,408,000 after purchasing an additional 18,389 shares in the last quarter. Wasatch Advisors LP increased its stake in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company's stock worth $62,160,000 after purchasing an additional 148,446 shares in the last quarter. Bank of America Corp DE raised its position in shares of Billiontoone by 8,603.4% during the 1st quarter. Bank of America Corp DE now owns 12,707 shares of the company's stock valued at $1,003,000 after purchasing an additional 12,561 shares during the period. Finally, Perceptive Advisors LLC boosted its holdings in Billiontoone by 26.1% in the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company's stock worth $7,248,000 after buying an additional 19,000 shares during the period.
About Billiontoone
(
Get Free Report)
BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company's molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient's blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Billiontoone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Billiontoone wasn't on the list.
While Billiontoone currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.